Objectives: 1. Introduction into saypha® range of HA fillers and their individual rheology.
2. Application and demonstration of saypha® range.
3. Discover how we can embed wellness into our use of dermal fillers in our aesthetic practices.

Introduction: Croma are delighted to introduce saypha® to the European market exclusively launching at IMCAS 2019. Led by Croma Global KOL Dr Rosh, this symposium will explore the revolutionary range, indications and techniques of application of the product. Alongside Dr Rosh; Kimberley Cairns will be exploring the importance of embedding patient welfare, wellness and understanding in the clinic experience curating the most unique experience and most importantly prosperous ethical business and client retention.

Conclusion: Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company that specialises in the industrial production of hyaluronic acid syringes for the fields of medical aesthetics, ophthalmology and orthopaedics. Croma’s Managing Director, Andreas Prinz explains “The saypha® brand reflects medical science and evidence based medicine, values that Croma felt committed to at any time. In short, by introducing saypha® we are creating a strong global HA filler brand that stands for comprehensive quality, reliability and medical effectiveness.”

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: Croma